Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
L275222-25μg | 25μg | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $1,133.90 | |
L275222-50μg | 50μg | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $1,875.90 |
Potent leukotriene C 4 receptor agonist
Synonyms | leukotriene C4|LTC4|72025-60-6|Leukotriene C|Leukotriene C1|LTC (sub 4)|Leucotriene C4|LTC4 (Leukotriene C4)|5S,6R-Ltc(sub 4)|LEUKOTRIENEC4|CHEBI:16978|2CU6TT9V48|CHEMBL451509|5S-hydroxy,6R-(S-glutathionyl),7E,9E,11Z,14Z-eicosatetraenoic acid|(5S,6R,7E,9E |
---|---|
Specifications & Purity | Moligand™, ≥97%, A solution in ethanol |
Biochemical and Physiological Mechanisms | Potent leukotriene C 4 receptor agonist (EC 50 = 300 nM). Lipid derivative of arachidonic acid and smooth muscle contractant (EC 50 = 11 nM). Causes coronary and renal vasoconstriction in vivo . |
Storage Temp | Protected from light,Store at -80°C |
Shipped In | Ice chest + Ice pads |
Grade | Moligand™ |
Action Type | AGONIST |
Mechanism of action | Agonist of CysLT 1 receptor;Agonist of CysLT 2 receptor;Agonist of GPR17 |
Note | Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -80°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details. |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IUPAC Name | (5S,6R,7E,9E,11Z,14Z)-6-[(2R)-2-[[(4S)-4-amino-4-carboxybutanoyl]amino]-3-(carboxymethylamino)-3-oxopropyl]sulfanyl-5-hydroxyicosa-7,9,11,14-tetraenoic acid |
---|---|
INCHI | InChI=1S/C30H47N3O9S/c1-2-3-4-5-6-7-8-9-10-11-12-13-16-25(24(34)15-14-17-27(36)37)43-21-23(29(40)32-20-28(38)39)33-26(35)19-18-22(31)30(41)42/h6-7,9-13,16,22-25,34H,2-5,8,14-15,17-21,31H2,1H3,(H,32,40)(H,33,35)(H,36,37)(H,38,39)(H,41,42)/b7-6-,10-9-,12-11+,16-13+/t22-,23-,24-,25+/m0/s1 |
InChi Key | GWNVDXQDILPJIG-NXOLIXFESA-N |
Canonical SMILES | CCCCCC=CCC=CC=CC=CC(C(CCCC(=O)O)O)SCC(C(=O)NCC(=O)O)NC(=O)CCC(C(=O)O)N |
Isomeric SMILES | CCCCC/C=C\C/C=C\C=C\C=C\[C@H]([C@H](CCCC(=O)O)O)SC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@@H](C(=O)O)N |
PubChem CID | 5280493 |
Molecular Weight | 625.77 |
Wikipedia | LTC4 |
---|---|
ChEBI | CHEBI:16978 |
CAS Registry No. | 72025-60-6 |
PubChem CID | 5280493 |
ChEMBL Ligand | CHEMBL451509 |
RCSB PDB Ligand | LTX |
GPCRdb Ligand | LTC4 |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
G23051219 | Certificate of Analysis | Apr 07, 2024 | L275222 |
K2208533 | Certificate of Analysis | Aug 14, 2023 | L275222 |
K2208521 | Certificate of Analysis | Aug 29, 2022 | L275222 |
Solubility | Supplied in methanol/ammonium acetate buffer, 65:35, pH5.6 (50 µg/ml) |
---|---|
Sensitivity | Light sensitive |
Pictogram(s) | GHS08 |
---|---|
Signal | Danger |
Hazard Statements | H350:May cause cancer |
Precautionary Statements | P280:Wear protective gloves/protective clothing/eye protection/face protection. P405:Store locked up. P501:Dispose of contents/container to ... P203:Obtain, read and follow all safety instructions before use. P318:if exposed or concerned, get medical advice. |